CANNAPHARMARX, INC.

CPMD ·Healthcare, Drug Manufacturers - General

SEC Filings

Form	Filed	Description
10-Q	Jun 25, 2024	FORM 10-Q FOR3/31/24
10-K	May 16, 2024	FORM 10-K FOR DECEMBER 2023
NT 10-Q	May 15, 2024	10-Q EXTENSION
NT 10-K	Mar 27, 2024	EXTENSION
8-K/A	Feb 22, 2024	FORM 8-K AMENDMENT
8-K	Feb 16, 2024	CURRENT REPORT
8-K	Dec 6, 2023	FORM 8-K
10-Q	Nov 17, 2023	FORM 10-Q FOR SEPT 2023
NT 10-Q	Nov 14, 2023	EXTENSION
8-K	Nov 13, 2023	FORM 8-K
8-K	Oct 13, 2023	CURRENT REPORT
10-Q	Oct 13, 2023	QUARTERLY REPORT
3	Oct 3, 2023	PRIMARY DOCUMENT
10-Q	Sep 22, 2023	FORM 10-Q
10-K	Sep 1, 2023	ANNUAL REPORT
8-K	Aug 28, 2023	CURRENT REPORT
8-K	Jun 23, 2023	CURRENT REPORT
NT 10-K	Mar 30, 2023	EXTENSION
10-Q	Nov 21, 2022	FORM 10-Q
NT 10-Q	Nov 14, 2022	REQUEST FOR EXTENSION
DEF 14A	Oct 4, 2022	DEF 14A
PRE 14A	Aug 26, 2022	PRE 14A
10-Q	Aug 22, 2022	FORM 10-Q
NT 10-Q	Aug 12, 2022	EXTENSION
EFFECT	Aug 11, 2022

← Newer Page 2 of 14 · 338 filings Older →